Castle Biosciences (NASDAQ:CSTL) shareholders have endured a 58% loss from investing in th
SWI Editorial Staff2025-07-27T10:45:51-07:00Simply Wall St 3 min read Generally speaking long term investing is the way to go. But along the way some stocks are going to perform badly. For example, after ...